Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia

Authors: Anuj Tiwari, Steaven Dandel, Rita Djupuri, Liesbeth Mieras, Jan Hendrik Richardus

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Indonesia ranking third in the world, regarding leprosy burden. Chemoprophylaxis is effective in reducing risk of developing leprosy among contacts. ‘Blanket approach’ is an operational strategy for leprosy post-exposure prophylaxis in which all members of an isolated community, high endemic for leprosy are screened and given a single dose of rifampicin (SDR) in the absence of signs and symptoms of leprosy. The objective is to assess the operational feasibility of a population-wide ‘blanket’ administration of SDR for leprosy prevention in isolated communities in a remote island.

Methods

A prospective follow-up study was conducted in the year 2014, 2015 and 2016 in Lingat village of Selaru Island, Indonesia. During the first two visits, screening and SDR were provided, whereas only screening was conducted during the third visit. The demographic and clinical data were used for a descriptive analysis of the project coverage and leprosy epidemiology.

Results

During the first two visits, 1671 persons (88%) were screened, 1499 (79%) received SDR, and 213 (11%) were excluded based on the exclusion criteria. During the first two visits, 43 (2.6%) cases were diagnosed with leprosy with a rate of 2263 per 100,000 population. The prevalence was highest in the age groups 15–24 and 25–49 years. Total, 14 (33%) cases had MB and 29 (67%) PB leprosy. Two cases (5%) had grade 2 disability. During the third visit, 10 new leprosy cases, with no grade 2 disability, were detected out of 1481 screened persons at the rate of 484 cases per 100,000 population (n = 2065 population in 2016). Among those screened during the third visit, there was a 50% reduction of leprosy among those who had previously received SDR compared to those who had not.

Conclusion

With adequate planning and some additional investment, it is feasible to implement a blanket approach of chemoprophylaxis in a remote island of Indonesia, although effort needs to be made to cover as many people as possible in the first visit. Contingency plans need to be made to actively follow this village closely in the coming years and continue leprosy elimination efforts until no new cases are found any more.
Appendix
Available only for authorised users
Literature
5.
go back to reference Global leprosy update, 2015: time for action, accountability and inclusion. Wkly Epidemiol Rec. 2016;91:405–20. Global leprosy update, 2015: time for action, accountability and inclusion. Wkly Epidemiol Rec. 2016;91:405–20.
9.
go back to reference The Indonesian Health Care System. Reducing Maternal and Neonatal Mortality in Indonesia: Saving lives, saving the future. Washington: National Academies Press (US); 2013. p. 39–52. The Indonesian Health Care System. Reducing Maternal and Neonatal Mortality in Indonesia: Saving lives, saving the future. Washington: National Academies Press (US); 2013. p. 39–52.
10.
go back to reference Global leprosy update, 2014: need for early case detection. Wkly Epidemiol Rec. 2015(90):461–74. Global leprosy update, 2014: need for early case detection. Wkly Epidemiol Rec. 2015(90):461–74.
16.
go back to reference Lusli M, Zweekhorst MBM, Miranda-Galarza B, Peters RMH. Dealing with stigma: experiences of persons affected by disabilities and leprosy. Biomed Res Int. 2015;2015:1–9.CrossRef Lusli M, Zweekhorst MBM, Miranda-Galarza B, Peters RMH. Dealing with stigma: experiences of persons affected by disabilities and leprosy. Biomed Res Int. 2015;2015:1–9.CrossRef
17.
go back to reference Gelber RH, Grosset J. The chemotherapy of leprosy: an interpretive history. Lepr Rev. 2012;83:221–40.PubMed Gelber RH, Grosset J. The chemotherapy of leprosy: an interpretive history. Lepr Rev. 2012;83:221–40.PubMed
19.
go back to reference Richardus JH, Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clin Dermatol. 2015;33:19–25.CrossRefPubMed Richardus JH, Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clin Dermatol. 2015;33:19–25.CrossRefPubMed
20.
go back to reference Smith WC, Aerts A. Role of contact tracing and prevention strategies in the interruption of leprosy transmission. Lepr Rev. 2014;85:2–17.PubMed Smith WC, Aerts A. Role of contact tracing and prevention strategies in the interruption of leprosy transmission. Lepr Rev. 2014;85:2–17.PubMed
21.
go back to reference Louhenapessy AA, Zuiderhoek B. A practical method of active case finding and epidemiological assessment: its origin and application in the leprosy control project in Indonesia. Int J Lepr Other Mycobact Dis. 1997;65:487–91.PubMed Louhenapessy AA, Zuiderhoek B. A practical method of active case finding and epidemiological assessment: its origin and application in the leprosy control project in Indonesia. Int J Lepr Other Mycobact Dis. 1997;65:487–91.PubMed
22.
go back to reference Bakker MI, Hatta M, Kwenang A. Prevention of leprosy using rifampicin as chemoprophylaxis. Am J Trop Med Hyg. 2005;72:443–8.PubMedCrossRef Bakker MI, Hatta M, Kwenang A. Prevention of leprosy using rifampicin as chemoprophylaxis. Am J Trop Med Hyg. 2005;72:443–8.PubMedCrossRef
23.
go back to reference Barth-Jaeggi T, Steinmann P, Mieras L, van Brakel W, Richardus JH, Tiwari A, et al. Leprosy post-exposure prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin. BMJ Open. 2016;6:e013633.CrossRefPubMedPubMedCentral Barth-Jaeggi T, Steinmann P, Mieras L, van Brakel W, Richardus JH, Tiwari A, et al. Leprosy post-exposure prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin. BMJ Open. 2016;6:e013633.CrossRefPubMedPubMedCentral
24.
go back to reference Cartel JL, Chanteau S, Boutin JP, Taylor R, Plichart R, Roux J, et al. Implementation of chemoprophylaxis of leprosy in the southern Marquesas with a single dose of 25 mg per kg rifampin. Int J Lepr Other Mycobact Dis. 1989;57:810–6.PubMed Cartel JL, Chanteau S, Boutin JP, Taylor R, Plichart R, Roux J, et al. Implementation of chemoprophylaxis of leprosy in the southern Marquesas with a single dose of 25 mg per kg rifampin. Int J Lepr Other Mycobact Dis. 1989;57:810–6.PubMed
25.
go back to reference Cartel JL, Chanteau S, Moulia-Pelat JP, Plichart R, Glaziou P, Boutin JP, et al. Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years. Int J Lepr Other Mycobact Dis. 1992;60:416–20.PubMed Cartel JL, Chanteau S, Moulia-Pelat JP, Plichart R, Glaziou P, Boutin JP, et al. Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years. Int J Lepr Other Mycobact Dis. 1992;60:416–20.PubMed
26.
go back to reference Nguyen LN, Cartel JL, Grosset JH. Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years. Lepr Rev. 2000;71 Suppl:S33–5. discussion S5–6PubMed Nguyen LN, Cartel JL, Grosset JH. Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years. Lepr Rev. 2000;71 Suppl:S33–5. discussion S5–6PubMed
27.
go back to reference Blanc LJ. Summary of leprosy chemoprophylaxis programs in the western Pacific region. Int J Lepr Other Mycobact Dis. 1999;67:S30–1. Blanc LJ. Summary of leprosy chemoprophylaxis programs in the western Pacific region. Int J Lepr Other Mycobact Dis. 1999;67:S30–1.
28.
go back to reference Diletto C, Blanc L, Levy L. Leprosy chemoprophylaxis in Micronesia. Lepr Rev. 2000;71 Suppl:S21–3. discussion S4–5PubMed Diletto C, Blanc L, Levy L. Leprosy chemoprophylaxis in Micronesia. Lepr Rev. 2000;71 Suppl:S21–3. discussion S4–5PubMed
30.
go back to reference Feenstra SG, Pahan D, Moet FJ, Oskam L, Richardus JH. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh. Lepr Rev. 2012;83:292–304.PubMed Feenstra SG, Pahan D, Moet FJ, Oskam L, Richardus JH. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh. Lepr Rev. 2012;83:292–304.PubMed
Metadata
Title
Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia
Authors
Anuj Tiwari
Steaven Dandel
Rita Djupuri
Liesbeth Mieras
Jan Hendrik Richardus
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3233-3

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue